As Trump administration cracks down on health care fraud, people with disabilities feel singled out
By O. Rose Broderick,
Stat
| 03. 18. 2026
Efforts to ‘crush’ fraud in Medicare and Medicaid will leave disabled Americans with fewer services, advocates worry
The Trump administration has zeroed in on its next target: ending health care fraud.
President Trump announced Monday the creation of a task force devoted to ending fraud, waste, and abuse in all federal benefits. On Tuesday, the administration expanded its Medicare and Medicaid fraud probe to Republican-led Florida.
The Centers for Medicare and Medicaid Services head Mehmet Oz — a former television star — has become the administration’s face, publishing numerous videos, social media posts and regulations that tout the agency’s commitment to crushing fraud in hospice, home health, durable medical equipment, and other industries. In January, CMS threatened to withhold roughly $2 billion in funding for 14 Medicaid services in Minnesota for the next year.
To the disability community, the crackdown feels less like the administration is rooting out crime and more like it is using fraud as an excuse to cut critical services — especially after the administration’s tax bill last year that slashed Medicaid funding by $1 trillion over 10 years, forcing state health officials to consider ending critical services like home care for ...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...